AMPH Stock: Price, Earnings History and SEC Filings
Amphastar Pharmaceuticals, Inc. (AMPH) last traded at $27.72, up 2.93% on the latest session and up 7.4% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.80 against an analyst estimate of $0.51, a beat of 56.9%.
$27.72 +2.93%
1 month+7.40%
52-week high$29.52
52-week low$16.65
Volume664,507
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
AMPH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.80 | $0.51 | +56.86% |
| Mar 2026 | May 7, 2026 | $0.26 | $0.62 | -58.06% |
| Dec 2025 | Feb 26, 2026 | $0.61 | $0.89 | -31.46% |
| Sep 2025 | Nov 6, 2025 | $0.83 | $0.73 | +13.70% |
AMPH beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for AMPH
SEC filing data is not available right now. You can search for AMPH on SEC EDGAR.
AMPH news
- 3 profitable stocks with warning signsOct 30, 2026 · finance.yahoo.com
- BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue EstimatesOct 29, 2026 · finance.yahoo.com
- Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out forOct 29, 2026 · finance.yahoo.com
- Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 5, 2026Oct 29, 2026 · finance.yahoo.com
- 3 value stocks that fall shortOct 29, 2026 · finance.yahoo.com
- Bausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesOct 28, 2026 · finance.yahoo.com
About Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. (AMPH) is a US-listed public company on Nasdaq.